CLAIM CARD
Quantitative findings from this preclinical work demonstrated a significant modulation of inflammatory and stress responses. The effect direction was null with respect to a simple anti-inflammatory interpretation, suggesting a more complex, context-dependent mechanism mediated by SIRT3. This indicates that the benefits of PCSK9 inhibition on cellular inflammation are not straightforward but depend on specific molecular contexts. The SIRT3-mediated pathway represents a plausible biological bridge between PCSK9 inhibition and longevity-associated cellular processes.
Evidence grade: exploratory
Contradiction status: none
Publication: 4753c82f-24d3-490c-8a23-6cc8d4194c24
Provenance: Derivation Web chain
Citation Support
source_1Ma 2025source_2Schwartz 2021source_3Lehrke 2024source_4Imran 2023source_5Faraidy 2023